Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592188 | SCV000703528 | uncertain significance | not provided | 2016-12-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001047948 | SCV001211934 | uncertain significance | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2024-08-28 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 59 of the RELN gene. It does not directly change the encoded amino acid sequence of the RELN protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs376881823, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with RELN-related conditions. ClinVar contains an entry for this variant (Variation ID: 498490). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |